Transcription of Hemoglobinopathies: Current Practices for Screening ...
{{id}} {{{paragraph}}}
hemoglobinopathies : Current Practices for Screening , confirmation and Follow-upDECEMBER 2015 ASSOCIATION OF PUBLIC HEALTH LABORATORIES 21 hemoglobinopathies : Current Practices for Screening , confirmation and Follow-upASSOCIATION OF PUBLIC HEALTH LABORATORIES 2 The mark CDC is owned by the US Dept. of Health and Human Services and is used with permission. Use of this logo is not an endorsement by HHS or CDC of any particular product, service, or publication was supported by Cooperative Agreement # U60HM000803 funded by the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of CDC or the Department of Health and Human Center for Immunization and Respiratory Diseases (IP)Office of Surveillance, Epidemiology and Laboratory Services (OSELS)National Center for HIV, Viral Hepatitis, STDs and TB Prevention (PS)National Center for Zoonotic, Vector-borne, and Enteric Diseases (CK)National Center for Environmental Health (NCEH)Coordinating Office for Terrorism Preparedness and Emergency Response (CTPER) Copyright 2015, Association of Public Health Laboratories.
Hemoglobinopathies: Current Practices for Screening, Confirmation and Follow-up 3 I. Executive Summary The hemoglobinopathies are a group of disorders passed down through families (inherited) in which there is abnormal production or structure of the hemoglobin molecule. Sickle cell disease (SCD) is one
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}